These mice develop tumors through a stepwise process (Zhang et al., 2017; Wang et al., 2018) and mimics the pathological procession of human CCA patients (Zhang et al., 2017), which validates the use of the YAP/AKT mouse model to study CCA in vivo. This evidence concerns the gene AKT1 and cholangiocarcinoma.